Medicare Enrolled

Dr. Daniel Cosgrove, MD

Urology Physician · Encino, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
16311 VENTURA BLVD, Encino, CA 91436
8789060635
In practice since 2005 (20 years)
NPI: 1790766491 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cosgrove from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cosgrove? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cosgrove

Dr. Daniel Cosgrove is an urology physician in Encino, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cosgrove performed 109,882 Medicare services across 7,645 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cosgrove received a total of $6,521 from 46 pharmaceutical and/or device companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cosgrove is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in CA $6,521 industry payments

Medicare Practice Summary

Medicare Utilization ↗
109,882
Medicare services
Top 1% in CA for urology physician
7,645
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,494 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
51,406 $0 $0
Testosterone undecanoate injection (Aveed)
An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection.
43,500 $1 $2
Urine culture, bacterial colony count
A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections.
1,716 $8 $35
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
1,713 $3 $18
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,563 $101 $197
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,083 $8 $15
PSA test (prostate cancer screening) 1,003 $18 $55
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
981 $92 $200
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
776 $18 $55
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
651 $12 $150
Antimicrobial drug evaluation
Assessment of the patient's response to antibiotic, antifungal, or antiviral therapy.
574 $7 $35
Bacterial culture, aerobic
A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms.
563 $8 $35
Free testosterone level test
A blood test that measures the amount of free testosterone in your body. Free testosterone is the portion of the hormone not bound to proteins and available for use by tissues.
534 $25 $61
Sex hormone binding globulin level test
A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream.
533 $21 $45
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
532 $25 $80
Urine culture, bacterial identification
A laboratory test that grows and identifies bacteria from a urine sample to detect infections.
481 $8 $24
Antibody screening test
A laboratory test used to detect the presence of specific antibodies in the blood. This screening helps identify immune responses to various conditions or exposures.
413 $11 $35
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
264 $10 $41
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
229 $12 $49
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
203 $51 $200
Fungal culture test
A laboratory test that grows and identifies mold or yeast from a sample to detect a fungal infection.
140 $8 $35
Bacterial culture and colony count
A laboratory test that grows bacteria from a sample to identify the type present and measure the quantity of bacterial growth.
131 $10 $35
Bacterial culture, non-urine, non-blood, non-stool
A laboratory test to identify bacteria from a sample other than urine, blood, or stool. The sample is grown in a lab to detect aerobic bacteria.
126 $9 $35
Total estradiol level test
A blood test that measures the total amount of estradiol, a form of estrogen, in the body.
120 $27 $55
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
113 $121 $304
Insertion of temporary bladder tube 102 $36 $105
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
100 $75 $130
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
93 $221 $415
Injection, garamycin, gentamicin, up to 80 mg 39 $2 $21
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
33 $150 $265
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
20 $68 $215
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
20 $300 $797
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
15 $2 $18
Follicle stimulating hormone (FSH) level
A blood test to measure the level of follicle stimulating hormone, a reproductive hormone.
15 $18 $40
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
14 $106 $546
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
14 $33 $133
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
14 $28 $186
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
14 $26 $254
Radiologist review of MRI guidance for needle placement
A radiologist reviews the MRI images to guide the placement of a needle. This step ensures accurate positioning during a medical procedure.
14 $61 $168
Luteinizing hormone level test
A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function.
14 $18 $40
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
13 $95 $168
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,521
Total received (2018-2024)
Avg $932/year across 7 years
Top 28% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
225
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,960 (76.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,306 (20.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,073
2023
$970
2022
$925
2021
$563
2020
$1,670
2019
$670
2018
$651

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$346
PROGENICS PHARMACEUTICALS, INC.
$175
Cleerly, Inc.
$80
Blue Earth Diagnostics Limited
$79
PFIZER INC.
$72
Endo USA, Inc.
$69
Endo Pharmaceuticals Inc.
$46
Becton, Dickinson and Company
$32
Bayer Healthcare Pharmaceuticals Inc.
$31
Boston Scientific Corporation
$25
Antares Pharma, Inc.
$22
Ferring Pharmaceuticals Inc.
$21
Sumitomo Pharma America, Inc.
$20
Myriad Genetic Laboratories, Inc.
$19
180 Medical, Inc.
$18
COLOPLAST CORP
$17
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
GE HEALTHCARE
$1,306
Endo Pharmaceuticals Inc.
$671
ABBVIE INC.
$395
PFIZER INC.
$385
Allergan, Inc.
$355
AbbVie Inc.
$320
Myriad Genetic Laboratories, Inc.
$286
Blue Earth Diagnostics Limited
$222
Astellas Pharma US Inc
$200
Antares Pharma, Inc.
$200
PROCEPT BioRobotics Corporation
$188
PROGENICS PHARMACEUTICALS, INC.
$175
Boston Scientific Corporation
$149
Coloplast Corp
$137
180 Medical, Inc.
$132
Dendreon Pharmaceuticals LLC
$105
Janssen Biotech, Inc.
$99
AbbVie, Inc.
$92
Cleerly, Inc.
$80
Progenics Pharmaceuticals, Inc.
$76
Endo USA, Inc.
$69
Sumitomo Pharma America, Inc.
$65
Myovant Sciences Inc.
$61
Tolmar, Inc.
$60
Olympus America Inc.
$48
MEDIVATION FIELD SOLUTIONS LLC
$48
Ferring Pharmaceuticals Inc.
$46
ConvaTec Inc.
$45
Allergan Inc.
$44
Clarus Therapeutics Inc.
$40
Avadel Specialty Pharmaceuticals, LLC
$40
Becton, Dickinson and Company
$32
Bayer Healthcare Pharmaceuticals Inc.
$31
Acerus Pharmaceuticals Corporation
$31
TOLMAR Pharmaceuticals, Inc.
$30
ABC Home Medical Supply, Inc.
$29
AKRIMAX PHARMACEUTICALS, LLC
$27
Profound Medical Corp.
$27
C. R. Bard, Inc. & Subsidiaries
$26
Zyla Life Sciences
$26
Supernus Pharmaceuticals, Inc.
$25
Metuchen Pharmaceuticals
$24
Augmenix, Inc.
$23
Aytu BioScience, Inc
$18
Merck Sharp & Dohme Corporation
$18
COLOPLAST CORP
$17
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AVEED · Axumin · BARDEX I.C. TIEMANN MODEL COUDE TIP FOLEY CATHETER · BOTOX · Bard Urinary Drainage Bag · Cleerly Ischemia · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · JATENZO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Rezum Generator · SPEEDICATH · SPRIX · SUTENT · SpaceOAR · SpeediCath · Stendra · TLANDO · TOVIAZ · Titan · UGN Laser Capital · Varithena Administration Pack · XIAFLEX · XTANDI · XYOSTED · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Encino?
Compare urology physicians in the Encino area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
337
Per 100K population
3.4
County median income
$87,760
Nearest hospital
ENCINO HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cosgrove is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cosgrove experienced with testosterone injection?
Based on Medicare claims data, Dr. Cosgrove performed 51,406 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cosgrove receive payments from pharmaceutical companies?
Yes. Dr. Cosgrove received a total of $6,521 from 46 companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cosgrove's costs compare to other urology physicians in Encino?
Dr. Cosgrove's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cosgrove) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →